Blood Proteins For Early Discrimination Of DEmentias
Funder
National Health and Medical Research Council
Funding Amount
$498,412.00
Summary
bPRIDE aims to develop blood biomarkers for early and specific diagnosis of the main dementia types: Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies, and use these to develop diagnostic tests.
COmBining Memantine And Cholinesterase Inhibitors In Lewy Body Dementia Treatment Trial (COBALT)
Funder
National Health and Medical Research Council
Funding Amount
$1,218,120.00
Summary
Many people who have been diagnosed with dementia with Lewy bodies or Parkinson’s disease dementia will be prescribed drugs known as acetylcholinesterase inhibitors (e.g. donepezil, rivastigmine, galantamine) to help with their symptoms. This research trial, known as COBALT, is designed to find out whether there is any benefit from taking the drug memantine as well. Australian and UK researchers are collaborating on this trial which will recruit eligible participants from both countries.
E-DiVA (empowering Dementia Carers With An ISupport Virtual Assistant)
Funder
National Health and Medical Research Council
Funding Amount
$1,857,363.00
Summary
We aim to translate the WHO iSupport tool to Bahasa, te reo Māori and Vietnamese, and culturally and contextually adapt the WHO iSupport program to fit the health and social care systems of Australia, Indonesia, New Zealand and Vietnam. A Virtual Assistant comprising a website and a smart-device app will be developed to allow carers to search topics and provide video instruction to support them in their caring role, and evaluated through a randomised controlled trial.